Thousand Oaks, CA – March 21st, 2025 – Rabble Health, a seed-stage company in digital patient engagement, is honored to announce its selection as a featured poster presenter at the American Thoracic Society (ATS) 2025 Respiratory Innovation Summit (RIS). The summit is scheduled for May 16-21, 2025, at the San Francisco Marriott Marquis, bringing together innovators, investors, clinicians, and advocacy groups dedicated to advancing respiratory health.

With over 12.5 million Americans living with uncontrolled asthma, Rabble Health addresses the critical need for accessible digital education and patient engagement tools. The company's myRabble platform, initially acclaimed for supporting breast cancer patients, has expanded to empower individuals with asthma. This free digital patient education app enables users to track symptoms, manage triggers, and adhere to personalized action plans, fostering improved health outcomes.​

"Being featured at the ATS 2025 RIS underscores the significance of patient-centric solutions in respiratory care," said Aubrey Kelly, CEO of Rabble Health. "Through myRabble, we aim to enhance patient self-management and facilitate informed conversations between patients and healthcare providers."​

The ATS 2025 Respiratory Innovation Summit serves as a premier platform for showcasing transformative innovations in pulmonary, critical care, and sleep medicine. Rabble Health’s poster presentation will highlight how patient-driven technology can enhance disease management and health outcomes for individuals living with asthma.​

For more information about Rabble Health and the myRabble platform, visit www.rabblehealth.com.

About Rabble Health

Rabble Health is a digital health company dedicated to empowering patients through digital education, patient engagement, and shared decision-making tools. By leveraging technology and behavioral science, Rabble Health helps patients with chronic conditions better manage their health and improve their quality of life.​

About the ATS Respiratory Innovation Summit

Hosted by the American Thoracic Society, the ATS Respiratory Innovation Summit unites innovators, investors, clinicians, and advocacy groups to accelerate the development of new treatments for respiratory diseases. The summit features presentations from leading companies and offers networking opportunities to foster collaboration in the respiratory health community.